| May-27-20 11:45AM | Hedge Funds Have Never Been This Bullish On iBio, Inc. (IBIO) Insider Monkey |
| May-22-20 09:05AM | 7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine InvestorPlace |
| May-21-20 02:44PM | 6 Top-Rated Stocks for a Post-Coronavirus-Crisis Bump InvestorPlace +5.07% |
| Apr-28-20 03:44PM | Why iBio's Stock Is Trading Higher Today Benzinga +22.26% |
| Apr-27-20 04:15PM | iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility GlobeNewswire |
| Apr-24-20 07:00AM | The Coronavirus Makes iBio Finally Relevant InvestorPlace -5.25% |
| Apr-09-20 07:30AM | iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute GlobeNewswire +6.61% |
| Apr-03-20 05:01AM | IBIO Stock Will Continue to Slide Lower After Speculative COVID-19 Surge InvestorPlace -9.22% |
| Mar-26-20 04:20PM | iBio Supporting AzarGen Biotechnologies Development of a Rituximab Biosimilar GlobeNewswire +7.14% |
| 07:30AM | iBio Announces Advancement of COVID-19 Vaccine Program GlobeNewswire |
| Mar-20-20 11:38AM | Dont Waste Time and Risk Capital on Coronavirus Play IBIO Stock InvestorPlace |
| 07:30AM | iBio Joins the Alliance for Biosecurity GlobeNewswire |
| Mar-18-20 08:00AM | iBio Announces Development of Proprietary COVID-19 Vaccine Candidates GlobeNewswire +40.35% |
| Mar-13-20 08:08AM | iBio Stock Is Unlikely a Coronavirus Winner and Thus a Real Gamble InvestorPlace +11.89% |
| Mar-12-20 04:45PM | iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO GlobeNewswire -9.49% |
| Mar-05-20 04:20PM | Dow notches another 900-point loss as benchmark government bond carves out new record low MarketWatch |
| 08:07AM | iBio stock surges 19% premarket on hopes for plans to develop plant-based coronavirus vaccine MarketWatch |
| Mar-02-20 04:30PM | iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split GlobeNewswire -9.80% |
| Feb-28-20 10:12AM | iBio shares soar another 174% on hopes for China vaccine partnership MarketWatch +183.24% |
| Feb-17-20 08:52AM | Here's Why iBio (NYSEMKT:IBIO) Must Play Its Cards Just Right Simply Wall St. |
| Feb-06-20 04:30PM | iBio, Inc. Announces Postponement of Annual Meeting GlobeNewswire |
| Feb-04-20 08:54AM | Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 4, 2020: GOOGL, DIS, EBAY, F, IBIO Benzinga +61.69% |
| Feb-03-20 04:15PM | iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine GlobeNewswire |
| Jan-16-20 08:00AM | iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire +8.52% |
| Jan-06-20 09:15AM | iBio Initiates New Litigation Against Fraunhofer GlobeNewswire -11.39% |
| Dec-23-19 09:30AM | EdgePoint announces collaboration with iBio CDMO to implement AI/Blockchain driven TrustPoint Vision Technology in its Texas cGMP facility GlobeNewswire -9.26% |
| 08:30AM | iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing GlobeNewswire |
| Dec-19-19 11:22AM | Is iBio, Inc.'s (NYSEMKT:IBIO) CEO Being Overpaid? Simply Wall St. |
| Dec-16-19 04:15PM | iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming GlobeNewswire -12.89% |
| Dec-13-19 05:00PM | iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire -7.98% |
| Dec-10-19 04:44PM | iBio Introduces FastGlycaneering Development Service to Power Recombinant Protein Production GlobeNewswire -9.39% |
| Dec-03-19 12:31PM | iBio Joins Manufacturing USAs Tissue Biofabrication Initiative GlobeNewswire +41.35% |
| Dec-02-19 04:15PM | iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference GlobeNewswire +20.04% |
| Oct-25-19 08:30AM | iBio, Inc. Prices $5,000,000 Public Offering GlobeNewswire -43.26% |
| Oct-22-19 04:30PM | iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire +15.10% |
| Sep-19-19 01:58PM | One Thing To Remember About The iBio, Inc. (NYSEMKT:IBIO) Share Price Simply Wall St. |
| Sep-17-19 04:15PM | iBios Collaboration with South Africas AzarGen Biotechnologies Advances to Next Stage GlobeNewswire |
| Aug-26-19 05:30PM | iBio and CC-Pharming Expand Business Collaboration in China GlobeNewswire -7.43% |
| Aug-21-19 12:15PM | A Look At Benzinga Pro's Most-Searched Tickers For August 21, 2019 Benzinga -7.87% |
| Aug-19-19 04:35PM | iBio Inks 3D Bioprinting Agreement GlobeNewswire |
| Jul-25-19 11:16AM | Did Changing Sentiment Drive iBio's (NYSEMKT:IBIO) Share Price Down A Painful 89%? Simply Wall St. |
| Jun-19-19 08:00AM | iBio Announces First Agreement for Fill-Finish Services GlobeNewswire |
| Jun-10-19 01:58PM | How Should Investors React To iBio, Inc.'s (NYSEMKT:IBIO) CEO Pay? Simply Wall St. |
| Jun-03-19 08:00AM | iBio Launches New Sterile Fill-Finish Services GlobeNewswire |
| Apr-24-19 02:03PM | What Type Of Shareholder Owns iBio, Inc.'s (NYSEMKT:IBIO)? Simply Wall St. |
| Apr-01-19 08:30AM | iBio Announces Appointment of Thomas F. Isett to Board of Directors GlobeNewswire |
| Dec-14-18 08:00AM | iBio Provides Status Update on its Continuing Litigation Against Fraunhofer GlobeNewswire |
| Dec-03-18 08:00AM | iBio to Present at Brazilian Ministry of Healths Plant-Made Pharmaceutical Meeting GlobeNewswire |
| Oct-02-18 08:00AM | iBio and CC-Pharming Hold First Design and Strategy Meeting GlobeNewswire +13.53% |
| Aug-22-18 04:10PM | iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire |
| Jul-09-18 08:00AM | iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China GlobeNewswire +8.00% |
| Jun-27-18 07:20AM | Free Technical Research on Nektar Therapeutics and Three More Biotech Equities ACCESSWIRE |
| Jun-26-18 06:59PM | iBio, Inc. Closes $16,000,000 Public Offering GlobeNewswire |
| Jun-22-18 07:26AM | iBio, Inc. Prices $16,000,000 Public Offering GlobeNewswire |
| Jun-08-18 04:30PM | iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split GlobeNewswire |
| 04:01PM | iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire |
| Jun-05-18 08:30AM | iBio and ONEWAY Diagnostica Develop New Products for Brazil GlobeNewswire +10.21% |
| Jun-04-18 05:46PM | Why iBio Incs (NYSEMKT:IBIO) Ownership Structure Is Important Simply Wall St. |
| May-31-18 08:30AM | iBio, Inc. Announces Reverse Stock Split GlobeNewswire -7.40% |
| May-24-18 07:15AM | Complimentary Technical Snapshots on Heat Biologics and Three More Biotech Stocks ACCESSWIRE |
| Apr-11-18 01:27PM | Should iBio Incs (NYSEMKT:IBIO) Recent Earnings Decline Worry You? Simply Wall St. -9.57% |
| Mar-14-18 08:30AM | iBio Selects Lead Candidate for its Fibrosis Therapeutics Program GlobeNewswire |
| Mar-12-18 08:30AM | iBio Patent Issues in China on Protein Glycosylation Modification GlobeNewswire |
| Mar-07-18 08:45AM | iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics GlobeNewswire +26.09% |
| Dec-18-17 03:44PM | ETFs with exposure to iBio, Inc. : December 18, 2017 Capital Cube +5.91% |
| Dec-08-17 02:53PM | iBio Inc (IBIO): Does -31.1% EPS Decline Lately Make It An Underperformer? Simply Wall St. |
| 01:03PM | ETFs with exposure to iBio, Inc. : December 8, 2017 Capital Cube |
| Nov-30-17 04:15PM | iBio, Inc. Closes $4,500,000 Offering of Common Stock GlobeNewswire |
| Nov-29-17 09:00AM | iBio, Inc. Prices $4,500,000 Firm Commitment Offering of Common Stock GlobeNewswire -31.61% |
| Nov-28-17 05:07PM | iBio, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire |
| Nov-27-17 02:12PM | ETFs with exposure to iBio, Inc. : November 27, 2017 Capital Cube |
| Nov-14-17 02:27PM | ETFs with exposure to iBio, Inc. : November 14, 2017 Capital Cube |
| Nov-13-17 09:20AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q1, 2018 By the Numbers : November 13, 2017 Capital Cube |
| Nov-08-17 12:00PM | AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research |
| Nov-06-17 05:00PM | iBio, Inc. Initiates Litigation Against Fraunhofer-Gesellschaft in Delaware Chancery Court GlobeNewswire |
| Oct-30-17 08:30AM | iBio CDMO President to Co-Chair South African Molecular Pharming Conference GlobeNewswire |
| Oct-24-17 09:39AM | ETFs with exposure to iBio, Inc. : October 24, 2017 Capital Cube -5.51% |
| Oct-23-17 08:00AM | IBio, Aethlon Agreement, The Biologics Market, and Analysts Target, CFB-03 Update ACCESSWIRE |
| Oct-18-17 07:00AM | Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE |
| Oct-16-17 07:15AM | iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire +5.00% |
| 07:15AM | Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire |
| Oct-13-17 10:56AM | ETFs with exposure to iBio, Inc. : October 13, 2017 Capital Cube |
| Oct-05-17 05:36PM | What Are The Drivers Of iBio Incs (IBIO) Risks? Simply Wall St. |
| Oct-04-17 09:00AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017 Capital Cube |
| Oct-02-17 10:54AM | ETFs with exposure to iBio, Inc. : October 2, 2017 Capital Cube |
| 08:30AM | iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development GlobeNewswire |
| Sep-20-17 05:40PM | ETFs with exposure to iBio, Inc. : September 20, 2017 Capital Cube +18.81% |
| 08:00AM | iBio, Inc. Intellectual Property Update GlobeNewswire |
| Sep-19-17 05:55PM | iBio Makes NYSE MKT Section 610(b) Public Announcement GlobeNewswire -11.35% |
| 02:27PM | iBio, Inc. :IBIO-US: Earnings Analysis: 2017 By the Numbers : September 19, 2017 Capital Cube |
| Sep-18-17 08:00AM | iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products GlobeNewswire +22.84% |
| Jul-25-17 07:12AM | AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B PR Newswire |
| Jul-24-17 08:30AM | iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital GlobeNewswire |
| Jul-12-17 01:00PM | Wednesdays Biotech Movers: Ibio Inc (IBIO) Rallies, Ocular Therapeutix Inc (OCUL) Tumbles, Alder Biopharmaceuticals Inc (ALDR) Dives SmarterAnalyst |
| 08:32AM | US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology PR Newswire |
| Jul-10-17 02:38PM | ETFs with exposure to iBio, Inc. : July 10, 2017 Capital Cube |
| Jun-05-17 02:21PM | ETFs with exposure to iBio, Inc. : June 5, 2017 Capital Cube |
| 08:30AM | iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference GlobeNewswire |
| May-25-17 12:41PM | ETFs with exposure to iBio, Inc. : May 25, 2017 Capital Cube |
| May-24-17 10:27AM | iBio, Inc. :IBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube |
